Related references
Note: Only part of the references are listed.Involvement of PKC delta (PKCδ) in the resistance against different doxorubicin analogs
Maria Ines Diaz Bessone et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Sustained inhibition of PKC alpha reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model
J. Kim et al.
ONCOGENE (2011)
Protein kinase C epsilon as a cancer marker and target for anticancer therapy
Ewa Toton et al.
PHARMACOLOGICAL REPORTS (2011)
PKCα expression is a marker for breast cancer aggressiveness
Gry Kalstad Lonne et al.
MOLECULAR CANCER (2010)
Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model
Valeria C. Grossoni et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
PKCη confers protection against apoptosis by inhibiting the pro-apoptotic JNK activity in MCF-7 cells
Noa Rotem-Dai et al.
EXPERIMENTAL CELL RESEARCH (2009)
Protein Kinase Cδ Supports Survival of MDA-MB-231 Breast Cancer Cells by Suppressing the ERK1/2 Pathway
Gry Kalstad Lonne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Down-Regulation of 3-Phosphoinositide-Dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells
Ying Liu et al.
MOLECULAR CANCER RESEARCH (2009)
Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer
J. W. Assender et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Protein kinase C δ inhibits the production of proteolytic enzymes in murine mammary cells
Valeria C. Grossoni et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Protein kinase C α is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells
Lisa B. Frankel et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Protein kinase Cι:: Human oncogene, prognostic marker and therapeutic target
Alan P. Fields et al.
PHARMACOLOGICAL RESEARCH (2007)
Protein kinase C δ enhances proliferation and survival of murine mammary cells
Valeria C. Grossoni et al.
MOLECULAR CARCINOGENESIS (2007)
Hormonal regulation of PKC:: Estrogen up-regulates PKCη expression in estrogen-responsive breast cancer cells
Galia Karp et al.
CANCER LETTERS (2007)
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner et al.
NATURE REVIEWS CANCER (2007)
Protein kinase C β enhances growth and expression of cyclin D1 in human breast cancer cells
Haiyang Li et al.
CANCER RESEARCH (2006)
Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma
Quintin Pan et al.
CANCER RESEARCH (2006)
Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCa and Src inhibitors
M. Tan et al.
ONCOGENE (2006)
Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cδ-dependent induction of p21
M Nakagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy
Q Pan et al.
CANCER RESEARCH (2005)
Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCδ-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation
I Vucenik et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Upregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells
SM Nabha et al.
ONCOGENE (2005)
Suppression of cell migration by protein kinase Cδ
D Jackson et al.
ONCOGENE (2005)
Protein kinase C ζ is required for epidermal growth factor-induced chemotaxis of human breast cancer cells
RH Sun et al.
CANCER RESEARCH (2005)
Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells
AJ Urtreger et al.
MOLECULAR CARCINOGENESIS (2005)
Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase Cα
C Kerfoot et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells
G Castoria et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Protein kinase C (PKC) βII induces cell invasion through a Ras/Mek-, PKCι/Rac1-dependent signaling pathway
J Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protein kinase C alpha expression in breast and ovarian cancer
M Lahn et al.
ONCOLOGY (2004)
Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway
Y Tanaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase C: a target for anticancer drugs?
HJ Mackay et al.
ENDOCRINE-RELATED CANCER (2003)
Protein kinase C lambda/iota (PKC lambda/iota): A PKC isotype essential for the development of multicellular organisms
A Suzuki et al.
JOURNAL OF BIOCHEMISTRY (2003)
Protein kinase Cα (PKCα):: Regulation and biological function
S Nakashima
JOURNAL OF BIOCHEMISTRY (2002)
Site-directed perturbation of protein kinase C-integrin interaction blocks carcinoma cell chemotaxis
M Parsons et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway
JF Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Isozyme-specific abnormalities of PKC in thyroid cancer: Evidence for post-transcriptional changes in PKC epsilon
JA Knauf et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras-1
S Kampfer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes α and θ
PK Gill et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Altered expression and localization of PKC eta in human breast tumors
PA Masso-Welch et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms
A Balendran et al.
FEBS LETTERS (2000)
Identification of PKC-isoform-specific biological actions using pharmacological approaches
KJ Way et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
Share Paper
